Compression And Constriction Of The Duodenum By A Carcinoma Of The Pancreatic Head. Abdominal X Ray In Front View.
"So the question was, what's different about these survivors compared to all other patients? And can we use this knowledge to transform this into new therapies that we could then apply to the other pancreatic cancer patients in an effort to maybe make them into long-term survivors?" Balachandran explained.
"I think the findings are encouraging that we can perhaps use more RNA vaccines that are personalized to treat pancreatic cancer and possibly other cancers," Balachandran continued. Earlier this month, a panel of experts at the FDA recommended Lynparza after a study found that pancreatic cancer patients who were treated with the drug could go nearly twice as long without their cancer worsening than those taking a placebo.
In patients who did not appear to respond to the vaccine, their cancers had come back on-average approximately 13 months after surgery. Pancreatic cancer: What you should know about the disease that led to Jerry Springer's death"All we have is a very interesting correlation, that we are now looking forward to testing in more pancreatic cancer patients as a next step," he added.